JP2009544722A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544722A5 JP2009544722A5 JP2009521925A JP2009521925A JP2009544722A5 JP 2009544722 A5 JP2009544722 A5 JP 2009544722A5 JP 2009521925 A JP2009521925 A JP 2009521925A JP 2009521925 A JP2009521925 A JP 2009521925A JP 2009544722 A5 JP2009544722 A5 JP 2009544722A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- concentration
- composition according
- cyclosporin
- polysorbate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 22
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 6
- 229930105110 Cyclosporin A Natural products 0.000 claims 5
- 108010036949 Cyclosporine Proteins 0.000 claims 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 229960001265 ciclosporin Drugs 0.000 claims 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 4
- 229920000053 polysorbate 80 Polymers 0.000 claims 4
- 229940068968 polysorbate 80 Drugs 0.000 claims 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 206010023644 Lacrimation increased Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 1
- 239000004327 boric acid Substances 0.000 claims 1
- 206010023332 keratitis Diseases 0.000 claims 1
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 1
- 230000004317 lacrimation Effects 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82023906P | 2006-07-25 | 2006-07-25 | |
| US82979606P | 2006-10-17 | 2006-10-17 | |
| US82980806P | 2006-10-17 | 2006-10-17 | |
| US86945906P | 2006-12-11 | 2006-12-11 | |
| US88352507P | 2007-01-05 | 2007-01-05 | |
| US91635207P | 2007-05-07 | 2007-05-07 | |
| PCT/US2007/074079 WO2008014200A2 (en) | 2006-07-25 | 2007-07-23 | Cyclosporin compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013184232A Division JP2014015471A (ja) | 2006-07-25 | 2013-09-05 | シクロスポリン組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009544722A JP2009544722A (ja) | 2009-12-17 |
| JP2009544722A5 true JP2009544722A5 (enExample) | 2010-09-09 |
Family
ID=38626720
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009521925A Pending JP2009544722A (ja) | 2006-07-25 | 2007-07-23 | シクロスポリン組成物 |
| JP2013184232A Pending JP2014015471A (ja) | 2006-07-25 | 2013-09-05 | シクロスポリン組成物 |
| JP2016002022A Pending JP2016106103A (ja) | 2006-07-25 | 2016-01-07 | シクロスポリン組成物 |
| JP2017055846A Pending JP2017132790A (ja) | 2006-07-25 | 2017-03-22 | シクロスポリン組成物 |
| JP2019039610A Pending JP2019108380A (ja) | 2006-07-25 | 2019-03-05 | シクロスポリン組成物 |
| JP2021020702A Pending JP2021075564A (ja) | 2006-07-25 | 2021-02-12 | シクロスポリン組成物 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013184232A Pending JP2014015471A (ja) | 2006-07-25 | 2013-09-05 | シクロスポリン組成物 |
| JP2016002022A Pending JP2016106103A (ja) | 2006-07-25 | 2016-01-07 | シクロスポリン組成物 |
| JP2017055846A Pending JP2017132790A (ja) | 2006-07-25 | 2017-03-22 | シクロスポリン組成物 |
| JP2019039610A Pending JP2019108380A (ja) | 2006-07-25 | 2019-03-05 | シクロスポリン組成物 |
| JP2021020702A Pending JP2021075564A (ja) | 2006-07-25 | 2021-02-12 | シクロスポリン組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US9561178B2 (enExample) |
| EP (2) | EP3124037A1 (enExample) |
| JP (6) | JP2009544722A (enExample) |
| KR (1) | KR20090053797A (enExample) |
| AU (1) | AU2007276815B2 (enExample) |
| BR (1) | BRPI0714727A2 (enExample) |
| CA (1) | CA2658518A1 (enExample) |
| IL (1) | IL196591A0 (enExample) |
| MX (1) | MX2009000843A (enExample) |
| NO (1) | NO20090305L (enExample) |
| WO (1) | WO2008014200A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| AU2016203191B2 (en) * | 2006-07-25 | 2018-03-01 | Allergan, Inc. | Cyclosporin compositions |
| US9561178B2 (en) * | 2006-07-25 | 2017-02-07 | Allergan, Inc. | Cyclosporin compositions |
| MX2010003364A (es) | 2007-10-08 | 2010-07-06 | Lux Biosciences Inc | Composiciones oftalmicas que comprenden inhibidores de calcineurina o inhibidores de mtor. |
| SA109300195B1 (ar) | 2008-03-28 | 2013-04-20 | Astrazeneca Ab | تركيبة صيدلانية جديدة مضادة للسرطان |
| US20110009339A1 (en) * | 2009-04-14 | 2011-01-13 | Allergan, Inc | Method of treating blurred vision and other conditions of the eye with cyclosporin compositions |
| WO2010127301A1 (en) * | 2009-05-01 | 2010-11-04 | Allergan, Inc. | Method of treating allergic conjunctivitis with cyclosporin compositions |
| US9017725B2 (en) * | 2009-06-09 | 2015-04-28 | Aurinia Pharmaceuticals Inc. | Topical drug delivery systems for ophthalmic use |
| EP2575854B1 (en) * | 2010-05-25 | 2016-03-09 | Allergan, Inc. | Cyclosporin emulsions |
| US20130029919A1 (en) | 2011-07-26 | 2013-01-31 | Allergan, Inc. | Two part formulation system for opthalmic delivery |
| AU2012339701B8 (en) * | 2011-11-15 | 2017-11-16 | Allergan, Inc. | Autoclavable suspensions of cyclosporin A Form 2 |
| EP2787969B1 (en) * | 2011-12-07 | 2021-09-29 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| FR2988297B1 (fr) * | 2012-03-22 | 2014-03-28 | Thea Lab | Solution ophtalmique aqueuse a base de ciclosporine a sans conservateur |
| AU2013267435B2 (en) | 2012-06-01 | 2017-11-09 | Allergan, Inc. | Cyclosporin A analogs |
| WO2014074605A1 (en) * | 2012-11-08 | 2014-05-15 | Allergan, Inc. | Preserved topical formulations with improved antimicrobial activity |
| JP6768653B2 (ja) | 2014-11-25 | 2020-10-14 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 安定したオメガ−３眼科用組成物 |
| WO2016112321A1 (en) | 2015-01-08 | 2016-07-14 | Allergan, Inc. | Cyclosporin derivatives wherein the mebmt sidechain has been cyclized |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| JP2020152674A (ja) * | 2019-03-20 | 2020-09-24 | 株式会社リコー | 難水溶性化合物の可溶化物の製造方法 |
| GR1010012B (el) * | 2020-05-12 | 2021-05-27 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον κυκλοσπορινη |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL194638C (nl) * | 1986-12-19 | 2002-10-04 | Novartis Ag | Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat. |
| JP2577049B2 (ja) * | 1987-06-04 | 1997-01-29 | 三共株式会社 | シクロスポリン製剤 |
| US5540931A (en) | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| US5294604A (en) | 1989-12-20 | 1994-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating ocular diseases by periocular administration of cyclosporine A or G |
| JPH0558906A (ja) * | 1991-09-06 | 1993-03-09 | Sankyo Co Ltd | シクロスポリン点眼製剤 |
| SG45449A1 (en) | 1992-05-13 | 1998-01-16 | Sandoz Ltd | Ophthalmic compositions |
| US5474979A (en) * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| US5565302A (en) * | 1995-04-21 | 1996-10-15 | W. R. Grace & Co.-Conn. | Process for preparing photosensitive resin composition |
| CA2284000C (en) | 1997-03-12 | 2012-01-03 | Abbott Laboratories | Hydrophilic binary systems for the administration of cyclosporine |
| JP2000143542A (ja) * | 1998-11-10 | 2000-05-23 | Wakamoto Pharmaceut Co Ltd | 難溶性免疫抑制剤含有ｏ／ｗエマルジョン製剤 |
| ES2206363T3 (es) | 2000-04-07 | 2004-05-16 | Laboratoire Medidom S.A. | Formulaciones oftalmicas a base de ciclosporina, de acido hialuronico y de polisorbato. |
| EP1301210A2 (en) * | 2000-07-14 | 2003-04-16 | Allergan, Inc. | Compositions containing therapeutically active components having enhanced solubility |
| KR20020050135A (ko) | 2000-12-20 | 2002-06-26 | 조명재 | 피부 주름 예방 및 완화를 목적으로 하는 피부 외용 조성물 |
| US6656460B2 (en) | 2001-11-01 | 2003-12-02 | Yissum Research Development | Method and composition for dry eye treatment |
| BR0117197A (pt) | 2001-12-14 | 2004-12-14 | Jagotec Ag | Formulação de medicamento contendo ciclosporina aplicação do mesmo |
| US20030165545A1 (en) * | 2002-01-30 | 2003-09-04 | Allergan, Inc. | Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US20050058696A1 (en) * | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| US20050059583A1 (en) * | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| US20050276867A1 (en) * | 2004-06-09 | 2005-12-15 | Allergan, Inc. | Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative |
| US20050277584A1 (en) | 2004-06-09 | 2005-12-15 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
| EP1827373B1 (en) | 2004-11-09 | 2008-12-03 | Novagali Pharma SA | Ophthalmic emulsions containing prostaglandins |
| WO2006073786A2 (en) | 2004-12-30 | 2006-07-13 | Bausch & Lomb Incorporated | Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
| US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
| PL1904056T3 (pl) | 2005-07-18 | 2009-09-30 | Minu Llc | Zastosowanie makrolidu do przywracania czucia rogówkowego |
| US7501393B2 (en) * | 2005-07-27 | 2009-03-10 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
| TWI435729B (zh) | 2005-11-09 | 2014-05-01 | Combinatorx Inc | 治療病症之方法，組合物及套組 |
| US9561178B2 (en) * | 2006-07-25 | 2017-02-07 | Allergan, Inc. | Cyclosporin compositions |
-
2007
- 2007-07-20 US US11/781,095 patent/US9561178B2/en not_active Expired - Fee Related
- 2007-07-23 MX MX2009000843A patent/MX2009000843A/es not_active Application Discontinuation
- 2007-07-23 BR BRPI0714727-9A patent/BRPI0714727A2/pt not_active IP Right Cessation
- 2007-07-23 EP EP16174365.3A patent/EP3124037A1/en not_active Withdrawn
- 2007-07-23 WO PCT/US2007/074079 patent/WO2008014200A2/en not_active Ceased
- 2007-07-23 EP EP07799758.3A patent/EP2043602B1/en not_active Not-in-force
- 2007-07-23 CA CA002658518A patent/CA2658518A1/en not_active Abandoned
- 2007-07-23 AU AU2007276815A patent/AU2007276815B2/en not_active Ceased
- 2007-07-23 KR KR1020097003774A patent/KR20090053797A/ko not_active Ceased
- 2007-07-23 JP JP2009521925A patent/JP2009544722A/ja active Pending
-
2008
- 2008-02-22 US US12/035,698 patent/US20080207495A1/en not_active Abandoned
-
2009
- 2009-01-19 IL IL196591A patent/IL196591A0/en unknown
- 2009-01-20 NO NO20090305A patent/NO20090305L/no not_active Application Discontinuation
-
2013
- 2013-09-05 JP JP2013184232A patent/JP2014015471A/ja active Pending
-
2016
- 2016-01-07 JP JP2016002022A patent/JP2016106103A/ja active Pending
-
2017
- 2017-02-06 US US15/425,836 patent/US20170143792A1/en not_active Abandoned
- 2017-03-22 JP JP2017055846A patent/JP2017132790A/ja active Pending
-
2019
- 2019-03-05 JP JP2019039610A patent/JP2019108380A/ja active Pending
-
2020
- 2020-10-07 US US17/064,988 patent/US20210169971A1/en not_active Abandoned
-
2021
- 2021-02-12 JP JP2021020702A patent/JP2021075564A/ja active Pending
-
2022
- 2022-05-12 US US17/663,188 patent/US20220409693A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544722A5 (enExample) | ||
| ES2324058T5 (es) | Solución oftálmica de bimatoprost mejorada | |
| ES2542728T3 (es) | Composiciones farmacéuticas que tienen la biodisponibilidad deseable | |
| JP2010222367A5 (enExample) | ||
| RU2012153786A (ru) | Стабильные многодозовые композиции, содержащие антитело и консервант | |
| JP2014516954A5 (enExample) | ||
| RU2013141845A (ru) | Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа | |
| AR064659A1 (es) | Nanoemulsion | |
| JP2019529457A5 (enExample) | ||
| JP2010538011A5 (enExample) | ||
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| CN108348781A (zh) | 用于治疗与线粒体活性氧簇(ros)产生相关的疾病的化合物 | |
| MX2009000843A (es) | Composiciones de ciclosporina. | |
| JP2016503058A5 (enExample) | ||
| RU2012103538A (ru) | Композиции и способы ингибирования пути jak | |
| JP2013537212A5 (enExample) | ||
| RU2014148758A (ru) | Офтальмологические композиции с улучшенной защитой от обезвоживания и удерживанием | |
| AR082049A1 (es) | Formulaciones liquidas de rupatadina fumarato | |
| JP2017511816A5 (enExample) | ||
| CN102066402B (zh) | 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物 | |
| RU2013129222A (ru) | Глазные композиции, содержащие мукоадгезивные полисахариды, способные стимулировать восстановление эпителия роговицы | |
| AR093297A1 (es) | Formulacion liquida que comprende un compuesto neutralizante de gm-csf | |
| JP2019515040A5 (enExample) | ||
| RU2012157219A (ru) | Местная фармацевтическая или косметическая композиция, применимая для лечения заболеваний или состояний, которые развиваются вследствии недостаточного созревания рогового конверта | |
| JP2015504860A5 (enExample) |